current user: public
If you have questions about the server, please let us know.

Query: 1uvg_A mol:protein length:78 SERINE PROTEINASE INHIBITOR KAZAL TYPE 5, from PDB1018

Results of FFAS03 search in PDB1018
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .
# Score Template Links and tools%idFirst GPDSEMCKDYRVLPRIGYLCPKDLKPVCGDDGQTYNNPCMLCHENLIRQTNTHIRSTGKCEESSTPGTTAASMPPSDELast
1 -41.0001uvg_A mol:protein length:78 SERINE PROTEINASE INHIBITOR KAZAL TYPE 5  ali model  100  1GPDSEMCKDYRVLPRIGYLCPKDLKPVCGDDGQTYNNPCMLCHENLIRQTNTHIRSTGKCEESSTPGTTAASMPPSDE 78
2 -29.5002leo_A mol:protein length:66 Serine protease inhibitor Kazal-type 7  ali model follow..  35  11....VDCSIYKKYPVVAIPCPITYLPVCGSDYITYGNECHLCTESLKSNGRVQFLHDGSC.................. 66
3 -29.4001h0z_A mol:protein length:68 SERINE PROTEASE INHIBITOR KAZAL-TYPE 5, CONTAINS HEMOFILTRATE PEPTIDE HF6478, HEMOFILTRATE PEPTIDE HF7665  ali model follow..  16  14.......EYRKLVRNGKLACTRENDPIQGPDGKVHGNTCSMCEVFFQAEEEEKKKKEGESRN................ 68
4 -29.2005yhn_A mol:protein length:69 cDNA FLJ60407, highly similar to Serine protease inhibitor Kazal-type 5  ali model follow..  20  1AEKDFCKEYEKQVRNGRLFCTRESDPVRGPDGRMHGNKCALCAEIFKRRFSEENSKTDQNLGKAEEKTK......... 69
5 -28.8001pce_A mol:protein length:60 PEC-60  ali model follow..  30  12...........EHMTESPDCSRIYDPVCGTDGVTYESECKLCLARIENKQDIQIVKDGEC.................. 60
6 -28.6001tbq_R mol:protein length:103 RHODNIIN  ali model follow..  30  1............EGGEPCACPHALHRVCGSDGETYSNPCTLNCAKFNGKPELVKVHDGPCEPDEDDGDEYKPVCGSD. 72
7 -28.5001kma_A mol:protein length:55 DIPETALIN  ali model follow..  34  2.............QGNPCECPRALHRVCGSDGNTYSNPCMLTCAKHEGNPDLVQVHEGPCDEHDH............. 53
8 -28.5002jxd_A mol:protein length:62 Serine protease inhibitor Kazal-type 2  ali model follow..  30  2.QFGLFSKYRTPNCSQLPGCPRHFNPVCGSDMSTYANECTLCMKIREGGHNIKIIRNGPC.................. 62
9 -28.4002n52_A mol:protein length:60 Serine protease inhibitor Kazal-type 6  ali model follow..  30  11..........GEFQDTKVYCTRESNPHCGSDGQTYGNKCAFCKAIVKSGGKISLKHPGKC.................. 60
10 -28.3002erw_A mol:protein length:56 serine protease inhibitor infestin  ali model follow..  32  1............EVRNPCACFRNYVPVCGSDGKTYGNPCMLNCAAQTKVPGLKLVHEGRCQRSNVEQ........... 55
11 -28.1001bus_A mol:protein length:57 PROTEINASE INHIBITOR IIA  ali model follow..  26  5.......VDCAEFKDPKVYCTRESNPHCGSNGETYGNKCAFCKAVMKSGGKINLKHRGKC.................. 57
12 -28.1004gi3_C mol:protein length:83 Greglin  ali model follow..  15  13.......EMSYTELPCPSICPLIYAPVCVEDSYLFVNECEVRKCGCEAGFVYTFVPREMCKATTS............. 74
13 -27.9002ovo_A mol:protein length:56 OVOMUCOID THIRD DOMAIN  ali model follow..  27  9............SEYPKPACTMEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 56
14 -27.8001m8b_A mol:protein length:56 Ovomucoid  ali model follow..  27  9............SEYPKDACTLEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 56
15 -27.6001ovo_A mol:protein length:56 OVOMUCOID THIRD DOMAIN  ali model follow..  35  9............SEYPKPACPKDYRPVCGSDNKTYSNKCNFCNAVVESNGTLTLNHFGKC.................. 56
16 -27.5001yu6_C mol:protein length:185 Ovomucoid  ali model follow..  27  139.............EYPKPACTLEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 185
17 -27.4001iy6_A mol:protein length:54 OMSVP3  ali model follow..  27  7............SEYPKCACTMEYRPLCGSDNKTYGNKCNFCCAVVESNGTLTLSHFGKC.................. 54
18 -26.9002f3c_I mol:protein length:55 thrombin inhibitor infestin  ali model follow..  31  3..............ENDCACPRVLHRVCGSDGNTYSNPCTLDCAKHEGKPDLVQVHEGPCDPNDH............. 53
19 -26.8002n71_A mol:protein length:50 Protease inhibitor 2  ali model follow..  32  1..........AEDCVGRKACTREWYPVCGSDGVTYSNPCNFSAQQEQCDPNITIAHMGEC.................. 50
20 -26.6001tgs_I mol:protein length:56 PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL TYPE)  ali model follow..  41  1.....TSPQREATCTSVSGCPKIYNPVCGTDGITYSNECVLCSENKKRQTPVLIQKSGPC.................. 56
21 -26.6001y1c_A mol:protein length:48 Elastase inhibitor  ali model follow..  35  1............KPDAPCICTMQYDPVCGSDGITYGNACMLLCASARSDTPIELVHKGRC.................. 48
22 -26.3002p6a_D mol:protein length:315 Follistatin  ali model follow..  18  241.............CDELCPDSKSDEPVCASDNATYASECAMKEAACSSGVLLEVKHSGSCNSISEDQDYSFPISSILE 314
23 -26.2005dae_A mol:protein length:65 AAEL006007-PA  ali model follow..  28  2..............RGVCACPRIYMPVCGSNLKTYNNDCLLRCEINSRANNLRKIADQACDNLTDNVNDFIPQ..... 63
24 -26.1001y1b_A mol:protein length:48 Elastase inhibitor  ali model follow..  35  1............KPDCPLICTMQYDPVCGSDGITYGNACMLLGASCRSDTPIELVHKGRC.................. 48
25 -26.0002arp_F mol:protein length:152 Follistatin  ali model follow..  25  106...............ICPEPSSSEQSLCGNDGVTYSSACHLRKATCLLGRSIGLAYEGKCIK................ 152
26 -26.0002sgq_I mol:protein length:51 Ovomucoid  ali model follow..  27  4............SEYPKPACTQEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
27 -25.9001cgj_I mol:protein length:56 PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL TYPE) VARIANT 4  ali model follow..  39  3.......LGREAKCYNLNGCTLEYRPVCGTDGDTYPNECVLCFENRKRQTSILIQKSGPC.................. 56
28 -25.9002nu2_I mol:protein length:51 Ovomucoid  ali model follow..  27  4............SEYPKPACTREYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
29 -25.9002nu0_I mol:protein length:51 Ovomucoid  ali model follow..  27  4............SEYPKPACTWEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
30 -25.9002nu1_I mol:protein length:51 Ovomucoid  ali model follow..  27  4............SEYPKPACTHEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
31 -25.9002gkt_I mol:protein length:51 Ovomucoid  ali model follow..  27  4............SEYPKPACTLEYRPLCGSDNKTYANKCNFCNAVVESNGTLTLSHFGKC.................. 51
32 -25.9001cgi_I mol:protein length:56 PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL TYPE) VARIANT 3  ali model follow..  39  3.......LGREAKCYNENGCTYEYRPVCGTDGDTYPNECVLCFENRKRQTSILIQKSGPC.................. 56
33 -25.9002sgp_I mol:protein length:51 OVOMUCOID INHIBITOR  ali model follow..  27  4............SEYPKPACTPEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
34 -25.8001ct0_I mol:protein length:51 OVOMUCOID INHIBITOR  ali model follow..  27  4............SEYPKPACTSEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
35 -25.8001ct2_I mol:protein length:51 OVOMUCOID INHIBITOR  ali model follow..  27  4............SEYPKPACTTEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
36 -25.8001ct4_I mol:protein length:51 OVOMUCOID INHIBITOR  ali model follow..  27  4............SEYPKPACTVEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
37 -25.8001hja_I mol:protein length:51 OVOMUCOID INHIBITOR  ali model follow..  29  4............SEYPKPACTKEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
38 -25.8001ds2_I mol:protein length:51 OVOMUCOID  ali model follow..  27  4............SEYPKPACTXEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
39 -25.8001sgp_I mol:protein length:51 TURKEY OVOMUCOID INHIBITOR  ali model follow..  27  4............SEYPKPACTAEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
40 -25.8001cso_I mol:protein length:51 OVOMUCOID INHIBITOR  ali model follow..  27  4............SEYPKPACTIEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
41 -25.8001sgd_I mol:protein length:51 Ovomucoid  ali model follow..  27  4............SEYPKPACTDEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
42 -25.8002sgf_I mol:protein length:51 Ovomucoid  ali model follow..  27  4............SEYPKPACTFEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
43 -25.7001sgn_I mol:protein length:51 Ovomucoid  ali model follow..  27  4............SEYPKPACTNEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
44 -25.7001sge_I mol:protein length:51 Ovomucoid  ali model follow..  27  4............SEYPKPACTEEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
45 -25.7001sgy_I mol:protein length:51 Ovomucoid  ali model follow..  27  4............SEYPKPACTYEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
46 -25.7001sgq_I mol:protein length:51 TURKEY OVOMUCOID INHIBITOR  ali model follow..  27  4............SEYPKPACTGEYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
47 -25.6001ds3_I mol:protein length:51 OVOMUCOID  ali model follow..  29  4............SEYPKPACTXDYRPLCGSDNKTYGNKCNFCNAVVESNGTLTLSHFGKC.................. 51
48 -25.4003b4v_C mol:protein length:237 follistatin-like 3  ali model follow..  13  170............RAAPCPVPSSPGQELCGNNNVTYISSCHMRQATCFLGRSIGVRHAGSCAGTPEEPPGGESAEEEEN 235
49 -24.1002n17_A mol:protein length:75 Lysozyme-Protease Inhibitor Protein  ali model follow..  25  4.......DDDDKPEDCQLFCPMIYAPICATDGRTFSNPCDLKVYNCWNDNPYKEVKVGECDDANK............. 65
50 -22.8002kcx_A mol:protein length:74 Follistatin-related protein 3  ali model follow..  23  18.......LGGRPRCECAPDCSPARLQVCGSDGATYRDECELRAARCRGHPDLSVMYRGRCRK................ 74
51 -21.6001uuc_A mol:protein length:55 SERINE PROTEASE INHIBITOR KAZAL-TYPE 5  ali model follow..  28  18...............GKLFCPQDKKPIQSLDGIMFINKCATCKMILEKEAKSQ......................... 55
52 -21.4002wcy_A mol:protein length:155 COMPLEMENT COMPONENT C7  ali model follow..  12  97.......ESSKCVCREASECEEEGFSICVEVNGKEQSECEAGALRC-RGQSISVTSIRPCAAETQ............. 155
53 -21.3001hdl_A mol:protein length:55 SERINE PROTEINASE INHIBITOR LEKTI  ali model follow..  29  22...................CPQDKKFFQSLDGIMFINKCATCKMILEKEAKSQ......................... 55
54 -21.0003tjq_A mol:protein length:140 Serine protease HTRA1  ali model follow..  28  81.............AQAGLCVCASSEPVCGSDANTYANLCQLRAASRRSERPVIVLQRGACGNS............... 134
55 -20.8003qtl_D mol:protein length:75 Kazal-type serine protease inhibitor SPI-1  ali model follow..  20  1.................APCPHTYKPVCGANGEVYDNECFLNKAGIE------PAESWETCRGHVCTEEYDPVCVEGK 60
56 -19.6003pis_D mol:protein length:42 Kazal-type serine protease inhibitor SPI-1  ali model follow..  34  2..................SCPHTYKPVCGANGEVYDNECFLNKAGIEP-----AESWETCRGHE.............. 42
57 -19.1001an1_I mol:protein length:46 TRYPTASE INHIBITOR  ali model follow..  44  1..............KKVCACPKILKPVCGSDGRTYANSCIARCNG------VSIKSEGSCPTG............... 43
58 -19.0001bmo_A mol:protein length:233 BM-40  ali model follow..  10  10GKVCELDENNTPMCVCQDPTSGEFEKVCSNDNKTFDSSCHFFATKCTLEGTKKGHKLHLDYIGP.............. 78
59 -18.0002v53_A mol:protein length:230 SPARC  ali model follow..  10  15GKVCELDENNTPMCVCQDPTSGEFEKVCSNDNKTFDSSCHFFATKCTLEGTKKGHKLHLDYIGPCKYIPPCLDSELTE 97
60 -17.7002m5x_A mol:protein length:40 Silk protease inhibitor 2  ali model follow..  36  2................AAVCTTEWDPVCGKDGKTYSNLCWLNEAG------VGLDHEGEC.................. 39
FFAS is supported by the NIH grant R01-GM087218-01
1 4 8 3 4 1   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Jaroszewski L, Slabinski L, Wooley J, Deacon AM, Lesley SA, Wilson IA, Godzik A. Genome pool strategy for structural coverage of protein families. Structure. 2008 Nov 12;16(11):1659-67.